drugset / Trial / NCT00004080
Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
Treatment
Summary
RATIONALE: Inserting the gene for p53 into a person's brain cells may improve the body's ability to fight cancer. PURPOSE: Phase I trial to study the effectiveness of p53 gene therapy with SCH-58500 in treating patients who have recurrent, or progressive glioblastoma multiforme, anaplastic astrocytoma, or anaplastic mixed glioma that can be removed during surgery.
Timeline
- Start
- 1999-12
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SCH-58500 | Gene therapy (AAV / viral vector) | — | Other |